CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹261 Cr | ₹372 Cr | ₹308 Cr | ₹240 Cr | ₹175 Cr |
What is the latest Consolidated Net Profit of CONCORD BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹261 Cr |
| Mar2025 | ₹372 Cr |
| Mar2024 | ₹308 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹175 Cr |
How is Consolidated Net Profit of CONCORD BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹261 Cr | -29.80 | |
| Mar2025 | ₹372 Cr | 20.62 | |
| Mar2024 | ₹308 Cr | 28.33 | |
| Mar2023 | ₹240 Cr | 37.25 | |
| Mar2022 | ₹175 Cr | - | |
Compare Consolidated Net Profit of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,798.3 Cr | -2.4% | 2.9% | -14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -2.4% |
2.9% |
-14% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses